ArticleCureus2025
Screening and Risk Assessment of Hepatitis B and C Among Medical Students and Non-teaching Staff of Services Institute of Medical Sciences, Lahore.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective This study aims to screen and assess the risk of hepatitis B and C among medical students and non-teaching staff at Services Institute of Medical Sciences (SIMS), Lahore. Material and methods This cross-sectional descriptive study was conducted at a screening camp using non-probability convenience sampling from September 7 to October 31, 2023. A total of 385 participants provided informed consent for both hepatitis screening and completing a modified form of the Hepatitis Risk Assessment Tool from the Centers for Disease Control and Prevention (CDC). Participants included medical students and non-teaching staff, regardless of comorbidities, who were not previously diagnosed with hepatitis B or C. Screening for hepatitis B and C was conducted using self-financed kits. Results Among the 385 participants, none tested positive for hepatitis B, while four participants tested positive for hepatitis C. The mean age of participants was 23.98 ± 6.686 years. Risk factor analysis revealed that 11 (3%) participants had a history of blood transfusion, and three (0.8%) reported prior dialysis. A total of 123 (32%) participants had undergone liver function tests (LFTs), with 34 (8.8%) showing abnormal results. Additionally, 216 participants had not received hepatitis B vaccination, and only 98 had completed the vaccination schedule. Furthermore, 51 (13%) participants had a history of injecting drugs. Conclusion Approximately half of the participants were vaccinated against hepatitis B, and a minimal proportion had elevated risks for hepatitis B and C. None tested positive for hepatitis B, and a small number were positive for hepatitis C, suggesting a differing prevalence of the two infections. Hepatitis screening should be routinely conducted in educational institutions, particularly for individuals with significant risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.